Name
Competence Centre for Cancer Research AS
Registry code
11015418
VAT number
EE100883541
Type
AS - Joint Stock Company
Status
Registered
Foundation date
13.02.2004 (21)
Financial year
01.01-31.12
Capital
50 000.00 €
Activity
70221 - Business and other management consultancy activities
-
-
-
-
-
-
-
No tax arrears
-
-
| Owner | Representative | Beneficial owner | Roles | |
|---|---|---|---|---|
| AS Bravo Pharmaceuticals 14159974 | 65% - 32 500.00 EUR | - | - | Shareholder |
| Nishant Kumar
| 35% - 17 500.00 EUR | - | - | Board memberShareholder |
| Rakesh Pandey
| - | Board member | - | |
| Ivo Nagel
| - | - | - | Board member |
| Reena Singh
| - | - | - | Board member |
| Aldago OÜ 10654228 | - | - | - | Founder |
| Andres Valkna
| - | - | - | Founder |
| Priit Kogerman
| - | - | - | Founder |
| Riin Ehin
| - | - | - | Founder |
| Owner | Representative | Beneficial owner | Roles | |
|---|---|---|---|---|
| MTÜ Personalised Medicine Association 80561497 | - | - | - | Founder (without contribution) |
| Turnover | State taxes | Labor taxes and payments | Employees | |
|---|---|---|---|---|
| 2024 Q4 | - | - | - | - |
| 2024 Q3 | - | - | - | - |
| 2024 Q2 | - | - | - | - |
| 2024 Q1 | 14 000 € | - | - | - |
| 2023 Q4 | 19 500 € | - | 463.75 € | - |
| 2023 Q3 | - | - | - | - |
| 2023 Q2 | - | - | - | - |
| 2023 Q1 | - | - | - | - |
| 2022 Q4 | - | - | - | - |
| 2022 Q3 | - | - | - | - |
| 2022 Q2 | - | - | - | - |
| 2022 Q1 | - | - | - | - |
| 2021 Q4 | 508.33 € | 101.92 € | - | - |
| 2021 Q3 | 2 250 € | 450 € | - | - |
| 2021 Q2 | - | - | - | - |
| 2021 Q1 | - | - | - | 1 |
| 2020 Q4 | - | - | - | 1 |
| 2020 Q3 | - | 335.15 € | 333.9 € | 1 |
| 2020 Q2 | 8 750 € | - | 1 001.7 € | 1 |
| 2020 Q1 | 52 000 € | - | 1 001.7 € | 1 |
